Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 97,353

Document Document Title
WO/2017/122815A1
Provided are a method for elucidating a polynucleotide which is a novel gene responsible for cancer, and detecting the polynucleotide or the polypeptide coded thereby on the basis of this finding; a kit and primer set for this detection;...  
WO/2017/122368A1
A culture promoter comprising a pyrrole compound is added to a medium in which an oxygen-generating photosynthetic organism is grown and then the medium is kept under the growth conditions of the organism. The aforesaid pyrrole compound ...  
WO/2017/124002A1
Provided herein are multispecific immunomodulatory antigen-binding constructs (MIACs) and compositions comprising the constructs. Also provided are methods of using the constructs and methods of making the constructs.  
WO/2017/122180A1
Provided herein are compositions and methods for the treatment of type 1 diabetes (T1D) in mammalian subjects. The compositions include lactic acid fermenting bacteria (LAB) expressing an IL-2 gene and a TID-specific self-antigen (e.g., ...  
WO/2017/122816A1
Provided are a detection method in which a polynucleotide, which is a gene newly discovered to be responsible for cancer, is elucidated, and on the basis of this finding, the polynucleotide or a polypeptide encoded by the polynucleotide ...  
WO/2017/123930A1
The present invention provides a non-naturally occurring microbe capable of growing in a medium comprising methanol, comprising a heterologous polynucleotide encoding a heterologous methanol dehydrogenase (MDH) derived from a Corynebacte...  
WO/2017/123775A1
This disclosure relates to modified alcohol dehydrogenases that metabolize methanol. The disclosure further relates to cells expressing such modified dehydrogenases and methods of producing biochemicals from methanol.  
WO/2017/123592A1
The present disclosure provides recombinant bacterial cells comprising a heterologous gene encoding a bile salt hydrolase enzyme and/or a 7α-dehydroxylating enzyme. In another aspect, the recombinant bacterial cells further comprise a b...  
WO/2017/124054A1
Methods and oligonucleotide reagents for diagnosing chikungunya virus and Zika virus infections are described. In particular, the invention relates to quantitative assays that can detect all lineages of chikungunya virus and Zika virus a...  
WO/2017/121307A1
The present invention provides an anti-C5aR antibody and a preparation method and use thereof. The anti-C5aR antibody comprises one or more of the following: a heavy chain CDR1, heavy chain CDR2 or heavy chain CDR3 of a heavy chain varia...  
WO/2017/123676A1
The present disclosure provides recombinant bacterial cells that have been engineered with genetic circuitry which allow the recombinant bacterial cells to sense a patient's internal environment and respond by turning an engineered metab...  
WO/2017/119795A1
The present invention relates to a novel Lactobacillus casei GFC1 strain (deposit number: KFCC18333P), a fermented ginseng extract using the strain, and a preparation method thereof. When the novel Lactobacillus casei GFC1 strain (deposi...  
WO/2017/120495A1
The disclosure relates to isolated microorganisms-including novel strains of the microorganisms-microbial consortia, and compositions comprising the same. Furthermore, the disclosure teaches methods of utilizing the described microorgani...  
WO/2017/115878A1
The present invention provides a novel method for diagnosing, treating or preventing mood disorders. A method for diagnosing, treating or preventing mood disorders, characterized by comprising measuring an antibody level of an antibody a...  
WO/2017/115826A1
The purpose is to provide a novel β-galactosidase useful in the production of oligosaccharides. Disclosed is a β-galactosidase including an amino acid sequence of any of SEQ ID NOS: 1-4 or an amino acid sequence having 80% or greater i...  
WO/2017/117425A1
The present invention provides recombinant algae expressing exogenous Type I fatty acid synthase (FAS) genes and demonstrating higher rates of fatty acid synthesis with respect to control microorganisms. The recombinant algae are able to...  
WO/2017/116856A1
The present invention relates to the use of phyllosphere-associated lactic acid bacteria that demonstrate inhibitory effects on the growth and maintenance of human pathogens, such as Salmonella enterica, on the surface of food products, ...  
WO/2017/115033A1
The invention relates to a method for producing a protein in a filamentous fungus cell, comprising the overexpression of the TrAZF1 gene or of one of the variants thereof in said cell.  
WO/2017/116161A1
The present invention relates to a composition for preventing odor, containing one or more types of odorless microorganisms selected from the group consisting of Caulobacter vibrioides, Bradyrhizobium diazoefficiens, Bradyrhizobium daqin...  
WO/2017/116846A1
The present disclosure provides aqueous inoculant compositions and methods for enhancing the survival and/or stability of microbial spores in an inoculant composition. In some embodiments, aqueous inoculant compositions of the present di...  
WO/2017/115774A1
Provided is a method for stably producing carotenoid at a high yield by means of microorganism culturing. The method for culturing carotenoid-producing bacteria is characterized in that a carotenoid-producing bacteria is cultured using a...  
WO/2017/114989A1
The invention relates to a method for the cultivation and pre-harvesting of algal biomass, comprising the following steps: a) introducing a culture medium that forms an algal biomass into a photobioreactor; b) promoting the growth of the...  
WO/2017/114403A1
A method for producing a yeast extract comprises steps: a) adding an enzyme composition to yeast comprising protein; b) incubating so as to hydrolyze the protein, wherein the enzyme composition comprises papain and a second protease.  
WO/2017/117233A1
The present invention proposes a recombinant strain of a pathogenic microorganism, comprised of an expression vector of an antigen derived from a parasite or disease vector, and a double vaccine comprising such a recombinant strain. In p...  
WO/2017/112984A1
The present invention is used in the field of processes and systems for increasing the thermal efficiency of combustion furnaces through bio-oxicombustion technology. The purpose of the integrated process for producing and using oxygen t...  
WO/2017/115000A1
The present invention relates to a new mismatch repair (MMR) system for Actinobacteria. The phased inactivation of the archaeon gene nucS (or an orthologous thereof) in Actinobacteria (including Mycobacterium and Streptomyces) increases ...  
WO/2017/115314A1
Exemplary embodiments of the present disclosure are directed towards a method that employs polybioinoculant compositions in a geo-specific and crop specific manner. The present invention also discloses polybioinoculant compositions compr...  
WO/2017/116644A1
The invention describes recombinant DNA sequences transcribed into RNA constructs capable of forming Virus Like Particles (VLPs) suitable for insect control applications. Specifically, the disclosure provides a method for controlling tar...  
WO/2017/117297A1
This document presents algae-derived antimicrobial plastic substrates, and a method of making the same. The plastic is preferably synthetic, but can also be formed as a bioplastic (e.g., polylactic acid). In various implementations, an a...  
WO/2017/116176A1
The present invention relates to: a method for screening for an antimicrobial agent capable of controlling microorganisms causing offensive odor in an air conditioning apparatus; and a method for removing offensive odor in the air condit...  
WO/2017/112998A1
The present invention relates to a method for transforming linalol-containing essential oils and producing mixtures of linalol derivatives useful as fragrances in cosmetic compositions.  
WO/2017/116837A1
The present disclosure provides non-aqueous inoculant compositions and methods for enhancing the survival and/or stability of microbial spores in an inoculant composition. In some embodiments, inoculant compositions of the present disclo...  
WO/2017/117539A1
Disclosed are components and systems for cell-free glycoprotein synthesis (CFGpS). In particular, the components and systems include and utilize prokaryotic cell lysates from engineered prokaryotic cell strains that have been engineered ...  
WO/2017/115853A1
A peptide having the following sequence is added as a peptide tag to a useful protein and expressed. Xm(PYn)qPZr Here, X, Y, and Z are amino acid residues each selected independently from R, G, S, K, T, L, N, Q, and H, and at l...  
WO/2017/116235A1
In the present document, a method for culturing and preserving the probiotic gut microorganism Eubacterium hallii is disclosed. The method provides an E. hallii preparation that is suitable for administration or ingestion to humans and t...  
WO/2017/117559A1
The present invention is directed to dry cell culture media or feeds comprising layered particles. The less stable or sensitive components are separated spatially from reactive components in media, feeds, supplements, or concentrates due...  
WO/2017/110963A1
To provide a novel method for manufacturing fumaric acid having good hue. A method for manufacturing fumaric acid, including steps (1) and (2), step (1) being a step for culturing a microorganism having the ability to produce fumaric aci...  
WO/2017/107545A1
Provided are a nucleic acid of an isolated encoding SCAP mutant, an isolated SCAP polypeptide, a method and a system for screening for biological samples that easily contract premature myocardial infarction, and a kit used to screen for ...  
WO/2017/107872A1
The present invention discloses a microbial attractant, and use. An active component of the attractant is a fermentation broth of Bacillus amyloliquefaciens YN2010-KC CGMCC No. 5722 with an effective live bacteria count ≧ 3×109 cfu/ml...  
WO/2017/108679A1
Novel Lactococcus lactissubsp. lactislactic acid bacterium strain having improved texturizing properties and method of using the strain for producing a food product.  
WO/2017/108126A1
The present invention relates to the use of at least one lactic acid bacterium, or a composition comprising thereof or conditioned thereby, for increasing or maintaining a Faecalibacterium prausnitzii population.  
WO/2017/112847A1
The invention provides an improved host strain for production of desired protein.  
WO/2017/109091A1
The present invention relates to a host cell which is capable of producing a dicarboxylic acid and which comprises at least one genetic modification in its genome resulting in the deficiency of at least one enzymatic step catalysing the ...  
WO/2017/112835A1
Photobioreactors having a vertically-oriented enclosure with a thin panel shape, systems providing mixing in an array of photobioreactors, and methods for using the same to culture productive organisms to accumulate biomass and/or make b...  
WO/2017/112471A1
Methods, systems, and compositions for propagating a fermentation microorganism that can have improved product yield during fermentation of a hydrolysate containing at least one growth inhibitor, including ethanol. In some embodiments, t...  
WO/2017/108577A1
The present invention relates to a recombinant yeast cell comprising a gene encoding a protein exhibiting lactyl-CoA synthase activity and a gene encoding a protein exhibiting lactyl-CoA polymerase activity, said recombinant cell having ...  
WO/2017/110626A1
Provided is a hydroponic culture method for a plant whereby the plant can be cultured over a long period of time in a high salinity environment. The hydroponic culture method for a plant in a high salinity environment comprises a culture...  
WO/2017/112475A1
Methods, systems, and compositions for propagating a fermentation microorganism that can have improved product yield during fermentation of a hydrolysate containing at least one growth inhibitor, including ethanol. In some embodiments, t...  
WO/2017/111092A1
The present invention addresses the problem of providing an agent for selective metal recovery, a metal recovery method and a metal elution method, whereby a metal can be selectively recovered, eluted , refined, etc. at low cost and high...  
WO/2017/112620A1
The invention is directed to antibacterial compositions comprising bacteria modified to comprise phasmids engineered to deliver of CRISPR RNAs and methods for their use.  

Matches 51 - 100 out of 97,353